Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Blood Cancer Journal|December 16, 2022
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapyGhulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory S Calip, et al.
Journal of Geriatric Oncology|December 17, 2023
Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability studyChristopher E Jensen, Allison M Deal, Kirsten A Nyrop, et al.
Informatics in Medicine Unlocked|November 4, 2024
SEETrials: Leveraging large language models for safety and efficacy extraction in oncology clinical trialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
SEETrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical TrialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Cancers|February 13, 2026
Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple MyelomaRaed Awadh Alshammari, Samuel M Rubinstein, Eric Farber-Eger, et al.
Journal of Geriatric Oncology|August 14, 2021
Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance statusChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.
Clinical and Translational Science|May 24, 2024
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myelomaSamia Shabnaz, Trang N Nguyen, Roy Williams, et al.
Frontiers in Cardiovascular Medicine|July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myelomaMarwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 9, 2022
Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple MyelomaAbdel Rahem S Yusuf, Hillary M Heiling, Allison M Deal, et al.
Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Blood Cancer Journal|December 16, 2022
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapyGhulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory S Calip, et al.
Journal of Geriatric Oncology|December 17, 2023
Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability studyChristopher E Jensen, Allison M Deal, Kirsten A Nyrop, et al.
Informatics in Medicine Unlocked|November 4, 2024
SEETrials: Leveraging large language models for safety and efficacy extraction in oncology clinical trialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
SEETrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical TrialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Cancers|February 13, 2026
Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple MyelomaRaed Awadh Alshammari, Samuel M Rubinstein, Eric Farber-Eger, et al.
Journal of Geriatric Oncology|August 14, 2021
Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance statusChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.
Clinical and Translational Science|May 24, 2024
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myelomaSamia Shabnaz, Trang N Nguyen, Roy Williams, et al.
Frontiers in Cardiovascular Medicine|July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myelomaMarwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 9, 2022
Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple MyelomaAbdel Rahem S Yusuf, Hillary M Heiling, Allison M Deal, et al.
Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.
Pageof 6